Latest Articles
ENDOSURE Develops 30-Minute Non-Invasive Test for Endometriosis Diagnosis - Femtech Insider
ENDOSURE Develops 30-Minute Non-Invasive Test for Endometriosis Diagnosis Femtech Insider
Published: Oct. 25, 2024, 11:03 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - The Week
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation The Week
Published: Oct. 25, 2024, 5:28 a.m.
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward Devdiscourse
Published: Oct. 25, 2024, 5:14 a.m.
Five Things You Need To Know About Endometriosis - Yale School of Medicine
Five Things You Need To Know About Endometriosis Yale School of Medicine
Published: Oct. 24, 2024, 10:23 p.m.
Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma
Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma
Published: Oct. 24, 2024, 9:31 p.m.
For Daisy Ridley, a Plant-Based Diet Is Key to Managing Her PCOS, Endometriosis, and Graves’ Disease - VegNews
For Daisy Ridley, a Plant-Based Diet Is Key to Managing Her PCOS, Endometriosis, and Graves’ Disease VegNews
Published: Oct. 24, 2024, 9:30 p.m.
Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease - Endometriosis Foundation of America - The Blossom
Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease Endometriosis Foundation of America - The Blossom
Published: Oct. 24, 2024, 7:10 p.m.
Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn
Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn
Published: Oct. 24, 2024, 6:26 p.m.
Execution of Kenyan in Saudi Arabia postponed by one year - The Standard
Execution of Kenyan in Saudi Arabia postponed by one year The Standard
Published: Oct. 24, 2024, 2:22 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Link copied to clipboard!